Novozymes finishes difficult 2019 burdened by bioenergy

The Danish enzyme producer landed an organic growth figure of -1 percent in 2019, significantly below the company's original guidance for the year. The company moreover initiates a share buyback program of EUR 200 million.

Photo: Novozymes/PR

Log in to read our articles

Welcome to EnergyWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles

Latest News


See all

See all